Richard Klausner Insider Trading $JUNO Juno Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Richard Klausner.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Richard Klausner. Richard Klausner is Sr VP, Chief Medical Officer in ILLUMINA INC ($ILMN) and Director in Juno Therapeutics, Inc. ($JUNO).
Richard Klausner in Juno Therapeutics, Inc.
Trading Symbol: JUNOIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Richard Klausner: Director
Holdings: 705,525 shares
Current Value: $14,646,699
Latest Transaction: Mar 07 2018
$JUNO Market Capitalization: $2.09B
$JUNO Previous Close: $20.76
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Richard Klausner in Juno Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 07 2018 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Option Exercise | D | 23.29 | 12,000 | 279,480 | 0 | |
Mar 07 2018 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Option Exercise | D | 42.40 | 12,000 | 508,800 | 0 | |
Mar 07 2018 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Option Exercise | D | 60.00 | 12,000 | 720,000 | 0 | |
Mar 07 2018 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Sell | U | 87.00 | 705,525 | 61,380,675 | 0 | 705.5 K to 0 (-100.00 %) |
Mar 07 2018 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Gift | G | 0.00 | 23,250 | 0 | 705,525 | 728.8 K to 705.5 K (-3.19 %) |
Jan 09 2018 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Sell | S | 49.37 | 918 | 45,321 | 728,775 | 729.7 K to 728.8 K (-0.13 %) |
Jan 09 2018 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Sell | S | 48.95 | 4,846 | 237,223 | 729,693 | 734.5 K to 729.7 K (-0.66 %) |
Jan 09 2018 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Sell | S | 47.80 | 5,011 | 239,538 | 734,539 | 739.6 K to 734.5 K (-0.68 %) |
Jan 09 2018 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Sell | S | 46.85 | 1,949 | 91,310 | 739,550 | 741.5 K to 739.6 K (-0.26 %) |
Jan 09 2018 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Grant | A | 0.00 | 248 | 0 | 741,499 | 741.3 K to 741.5 K (+0.03 %) |
Dec 22 2017 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Sell | S | 45.16 | 3,141 | 141,849 | 741,251 | 744.4 K to 741.3 K (-0.42 %) |
Dec 22 2017 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Sell | S | 44.72 | 32,859 | 1,469,507 | 744,392 | 777.3 K to 744.4 K (-4.23 %) |
Oct 06 2017 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Grant | A | 0.00 | 266 | 0 | 777,251 | 777 K to 777.3 K (+0.03 %) |
Sep 08 2017 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Sell | S | 43.83 | 1,337 | 58,605 | 776,985 | 778.3 K to 777 K (-0.17 %) |
Sep 08 2017 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Sell | S | 42.76 | 5,214 | 222,940 | 778,322 | 783.5 K to 778.3 K (-0.67 %) |
Sep 08 2017 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Sell | S | 42.27 | 5,449 | 230,321 | 783,536 | 789 K to 783.5 K (-0.69 %) |
Aug 09 2017 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Sell | S | 30.34 | 12,000 | 364,091 | 788,985 | 801 K to 789 K (-1.50 %) |
Jul 07 2017 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Sell | S | 30.00 | 400 | 11,999 | 800,985 | 801.4 K to 801 K (-0.05 %) |
Jul 07 2017 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Sell | S | 29.38 | 23,600 | 693,321 | 801,385 | 825 K to 801.4 K (-2.86 %) |
Jul 07 2017 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Grant | A | 0.00 | 380 | 0 | 824,985 | 824.6 K to 825 K (+0.05 %) |
Jun 19 2017 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Option Exercise | A | 23.29 | 12,000 | 279,480 | 12,000 | |
Jun 09 2017 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Sell | S | 24.24 | 8,768 | 212,528 | 824,605 | 833.4 K to 824.6 K (-1.05 %) |
Jun 09 2017 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Sell | S | 23.23 | 15,232 | 353,833 | 833,373 | 848.6 K to 833.4 K (-1.79 %) |
Apr 06 2017 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Grant | A | 0.00 | 514 | 0 | 848,605 | 848.1 K to 848.6 K (+0.06 %) |
Jan 09 2017 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Grant | A | 0.00 | 591 | 0 | 848,091 | 847.5 K to 848.1 K (+0.07 %) |
Oct 17 2016 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Grant | A | 0.00 | 401 | 0 | 847,500 | 847.1 K to 847.5 K (+0.05 %) |
Jul 05 2016 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Grant | A | 0.00 | 300 | 0 | 847,099 | 846.8 K to 847.1 K (+0.04 %) |
Jun 24 2016 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Sell | S | 40.71 | 12,000 | 488,496 | 846,799 | 858.8 K to 846.8 K (-1.40 %) |
Jun 21 2016 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Option Exercise | A | 42.40 | 12,000 | 508,800 | 12,000 | |
May 20 2016 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Sell | S | 40.00 | 12,000 | 480,000 | 858,799 | 870.8 K to 858.8 K (-1.38 %) |
Apr 07 2016 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Grant | A | 0.00 | 300 | 0 | 882,799 | 882.5 K to 882.8 K (+0.03 %) |
Mar 22 2016 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Sell | S | 40.00 | 12,000 | 480,000 | 882,499 | 894.5 K to 882.5 K (-1.34 %) |
Mar 02 2016 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Sell | S | 41.22 | 760 | 31,327 | 894,499 | 895.3 K to 894.5 K (-0.08 %) |
Mar 02 2016 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Sell | S | 40.39 | 23,240 | 938,696 | 895,259 | 918.5 K to 895.3 K (-2.53 %) |
Apr 19 2016 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Sell | S | 43.51 | 1,993 | 86,707 | 870,799 | 872.8 K to 870.8 K (-0.23 %) |
Apr 19 2016 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Sell | S | 42.79 | 10,007 | 428,150 | 872,792 | 882.8 K to 872.8 K (-1.13 %) |
Dec 17 2015 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Sell | S | 46.62 | 4,085 | 190,459 | 918,499 | 922.6 K to 918.5 K (-0.44 %) |
Dec 17 2015 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Sell | S | 45.74 | 3,700 | 169,236 | 922,584 | 926.3 K to 922.6 K (-0.40 %) |
Dec 17 2015 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Sell | S | 44.81 | 4,215 | 188,866 | 926,284 | 930.5 K to 926.3 K (-0.45 %) |
Nov 13 2015 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Sell | S | 50.18 | 500 | 25,091 | 930,499 | 931 K to 930.5 K (-0.05 %) |
Nov 13 2015 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Sell | S | 49.48 | 11,500 | 568,987 | 930,999 | 942.5 K to 931 K (-1.22 %) |
Oct 16 2015 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Sell | S | 50.00 | 8,000 | 400,000 | 942,499 | 950.5 K to 942.5 K (-0.84 %) |
Oct 13 2015 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Sell | S | 50.00 | 16,000 | 800,008 | 950,499 | 966.5 K to 950.5 K (-1.66 %) |
Jul 17 2015 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Sell | S | 53.94 | 117 | 6,311 | 966,499 | 966.6 K to 966.5 K (-0.01 %) |
Jul 17 2015 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Sell | S | 53.33 | 7,883 | 420,415 | 966,616 | 974.5 K to 966.6 K (-0.81 %) |
Jun 25 2015 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Sell | S | 52.77 | 3,101 | 163,639 | 974,499 | 977.6 K to 974.5 K (-0.32 %) |
Jun 25 2015 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Sell | S | 51.98 | 4,899 | 254,663 | 977,600 | 982.5 K to 977.6 K (-0.50 %) |
Jun 16 2015 | JUNO | Juno Therapeutics, ... | Klausner Richard | Director | Option Exercise | A | 60.00 | 12,000 | 720,000 | 12,000 |
Page: 1